Flexible Dose, Long-term Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05897)

Clinical trial NCT01190267 · COMPLETED

Trial details

NCT number: NCT01190267
Sponsor: Organon and Co
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Schizophrenia, Paranoid Schizophrenia, Disorganized Schizophrenia, Undifferentiated

Start date: 2010-09-28
Primary completion: 2013-10-07
Enrollment: 204

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.